Biocryst Pharmaceuticals (BCRX) Change in Accured Expenses (2010 - 2022)
Biocryst Pharmaceuticals (BCRX) posted Change in Accured Expenses of -$6.35 million for Q4 2022, compared with $284,000 a year earlier.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Change in Accured Expenses (2010 - 2022) Analysis & Trends
For FY2021, Biocryst Pharmaceuticals' Change in Accured Expenses came in at $4.17 million, down 38.4% from FY2020.
- Annual Change in Accured Expenses shows a five-year compound annual growth rate of 13.2% (FY2016 to FY2021).
- In prior years, Biocryst Pharmaceuticals' Change in Accured Expenses was $6.77 million in FY2020 (+121.4%), $3.06 million in FY2019, -$247,000 in FY2018 and $3.11 million in FY2017 (+38.4%).
- The Q4 2022 figure stands as the lowest quarterly Change in Accured Expenses since Q1 2013.
- On a year-over-year basis, Change in Accured Expenses increased in two of the last four quarters, with an average decline of 30.3%.
- The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q4 2020, with growth of 59.8%; the weakest was Q4 2021, with a decline of 88.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.09 Bn | 1.01 Bn | 214.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -6.35 Mn |
| Sep 30, 2022 | 6.35 Mn |
| Dec 31, 2021 | 284,000.00 |
| Sep 30, 2021 | 337,000.00 |
| Jun 30, 2021 | 1.67 Mn |
| Mar 31, 2021 | 1.88 Mn |
| Dec 31, 2020 | 2.37 Mn |
| Sep 30, 2020 | 1.50 Mn |
| Jun 30, 2020 | 1.43 Mn |
| Mar 31, 2020 | 1.48 Mn |
| Dec 31, 2019 | 1.48 Mn |
| Sep 30, 2019 | -1.32 Mn |
| Jun 30, 2019 | 1.35 Mn |
| Mar 31, 2019 | 1.54 Mn |
| Dec 31, 2018 | 1.42 Mn |
| Sep 30, 2018 | -4.41 Mn |
| Jun 30, 2018 | 1.37 Mn |
| Mar 31, 2018 | 1.37 Mn |
| Dec 31, 2017 | 1.39 Mn |
| Sep 30, 2017 | -882,000.00 |
API Access
Biocryst Pharmaceuticals Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();